What this page helps you decide
Compare Rayyan, Covidence, ASReview, RobotReviewer, EPPI-Reviewer, and citation workflows for title-abstract screening, conflict resolution, audit trails, and PRISMA-ready review records. The practical decision is whether this workflow improves the research task while preserving traceability, source review, and a clear record of what changed between the first draft and the final claim.
Choose a screening tool by the review record it leaves behind: independent decisions, conflicts, exclusion reasons, exports, and PRISMA traceability matter more than a polished interface. AI prioritization is useful only when reviewers can still audit every decision. Start from the specific task, decide what evidence must be checked, and keep the final research claim tied to sources another person can inspect.
Who should use it first
Systematic review authors, evidence synthesis teams, medical students, librarians, and research assistants comparing paper screening tools before committing a protocol or team workflow.
The first action is deliberately small: Define inclusion criteria, reviewer roles, conflict rules, and export needs before importing citations into Rayyan, Covidence, ASReview, RobotReviewer, or any screening workspace. That small trial should produce a visible record of inputs, outputs, sources, decisions, and unresolved questions before the workflow is used on a manuscript, report, grant, or formal review.
Scenario notes
You need fast title and abstract screening with two reviewers
Use it when: Use Rayyan or a similar screening workspace when the main job is blinded decisions, labels, conflicts, and exportable inclusion records.
Avoid it when: Avoid treating a simple screening workspace as the full systematic review system if you also need extraction, risk-of-bias management, and PRISMA reporting in one place.
Your team has thousands of records or needs active learning
Use it when: Use ASReview or another prioritization workflow to surface likely inclusions earlier while reviewers continue to make accountable decisions.
Avoid it when: Avoid excluding papers automatically unless the protocol, validation set, and human review process make that defensible.
Step-by-step working version
Step 1
Deduplicate records in Zotero, EndNote, Covidence, or a review manager before screening starts.
Record the source, decision, owner, and next check before moving on. This keeps the workflow auditable instead of becoming a one-off AI output.
Step 2
Import titles and abstracts, then pilot inclusion criteria on a small sample until reviewers agree on edge cases.
Record the source, decision, owner, and next check before moving on. This keeps the workflow auditable instead of becoming a one-off AI output.
Step 3
Run independent screening, record conflicts, and resolve disagreements with documented reasons.
Record the source, decision, owner, and next check before moving on. This keeps the workflow auditable instead of becoming a one-off AI output.
Step 4
Use AI prioritization or RobotReviewer-style signals as triage aids, not as final inclusion or bias decisions.
Record the source, decision, owner, and next check before moving on. This keeps the workflow auditable instead of becoming a one-off AI output.
Step 5
Export decisions, exclusion reasons, reviewer agreement, and citation identifiers before moving to full-text screening.
Record the source, decision, owner, and next check before moving on. This keeps the workflow auditable instead of becoming a one-off AI output.
How to choose the next move
Paper screening tool for systematic review
Start with Rayyan for lightweight title-abstract screening or Covidence when the review team needs a broader managed workflow.
Next: Run a pilot screening set, check conflicts, and confirm export fields before screening the full corpus.
AI systematic review screening
Consider ASReview for active-learning prioritization and RobotReviewer for bias-of-risk prompts.
Next: Keep human inclusion decisions and validate any AI-assisted stopping or prioritization rule.
Rayyan vs Covidence
Use Rayyan when speed and simple screening are enough; use Covidence when extraction, team workflow, and PRISMA records are central.
Next: Compare cost, reviewer seats, export needs, and whether your institution already has access.
Rayyan
Fast title and abstract screening, labels, blinded decisions, and conflict resolution for many review teams.
It is strongest as a screening workspace; plan separate extraction, bias, and synthesis steps when needed.
Covidence
Team systematic review workflow across screening, full text, extraction, and review records.
Heavier workflow and access constraints can be unnecessary for a small narrative or scoping project.
ASReview
Active-learning prioritization when the record set is large and reviewers want likely inclusions earlier.
Prioritization is not the same as defensible exclusion unless the protocol supports it.
Before you rely on the output
Failure points to check
- - A screening tool is not automatically a full evidence synthesis platform.
- - AI ranking can speed up review, but it can also hide minority evidence if the stopping rule is weak.
- - For medical reviews, keep DOI, PMID, database source, search date, and exclusion reasons visible in the final audit trail.
Evidence checklist
- - Can the tool export every decision with reviewer, date, conflict status, and reason?
- - Can another reviewer reproduce the screening set from the original database search and deduplication record?
- - Does the workflow preserve records needed for PRISMA, full-text retrieval, and risk-of-bias assessment?
Bottom line for Paper screening tools for systematic reviews
A strong result is not the fastest output. It is the output that can be checked against the original source, repeated by another researcher, and revised without losing the reasoning trail.